India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Lofty has unveiled Lofty AOS, an autonomous AI operating system built to transform how real estate brokerages manage daily operations. Unlike traditional AI tools that wait for prompts, Lofty AOS uses coordinated AI agents to proactively run workflows—from lead management to social media posting—allowing agents to focus on revenue‑producing activities. Designed for control, compliance and seamless integration, this new system signals a major shift in how real estate professionals scale productivity in an increasingly tech‑driven market.
A national survey shows a major shift in how Americans approach estate planning, with 41% now turning to financial advisors before attorneys. Consumers increasingly expect advisors to guide not only wealth transfer, but also values, family communication, and preparing the next generation — creating a powerful opportunity for professionals across real estate, mortgage, insurance, and finance.
A new CBRE survey shows a strong surge in investor optimism as the commercial real estate market begins to stabilize after two turbulent years. Nearly all investors expect to buy the same or more property in 2026, with over half planning to increase their capital allocations. Dallas remains the nation’s top investment market, multifamily leads all asset classes, and moderate‑risk value‑add strategies dominate as confidence and capital return to the sector.
Conversational AI is changing the way real estate professionals create and market listing photos. Instead of waiting for perfect conditions or hiring photo editors, agents and property managers can now brighten rooms, remove clutter, change wall colors, or even virtually stage a space using simple text prompts. The technology helps listings hit the market faster, gives renters and buyers clearer first impressions, and supports more honest, transparent marketing through features like before‑and‑after sliders and edit labels. As AI becomes an essential skill in real estate and related industries, tools like these are redefining how professionals communicate a property’s true potential.
Artificial intelligence is transforming Des Moines’ finance and insurance sectors—home to giants like Wells Fargo, Principal, Nationwide, and Athene. With AI taking over routine quantitative work, the metro faces both economic disruption and new possibilities. While entry‑level roles may shrink, experts say human talent will shift toward strategy, client guidance, and innovation. The ripple effects extend far beyond office walls, raising questions about community vitality, future leadership pipelines, and how today’s professionals can stay competitive through upskilling and ongoing education.
The property management sector is undergoing rapid transformation driven by AI, IoT building systems, automation, and digital platforms. A new report from The Business Research Company projects the market will hit $33.93 billion by 2030, highlighting major shifts such as remote oversight tools, predictive maintenance, and cloud‑based solutions. Industry giants like IBM, Yardi, AppFolio, and JLL are leading the charge, while consolidation moves—such as MCB Real Estate’s acquisition of Pinkard Properties—signal continued expansion. Vacation rental tech is also accelerating, with unified platforms like Streamline One redefining short‑term rental operations. This evolving landscape underscores the growing need for skilled, tech‑savvy real estate professionals.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
